(2025). Retraction Notice: Dihydromyricetin Exhibits Antitumor Activity in Nasopharyngeal Cancer Cell Through Antagonizing Wnt/β-Catenin Signaling. SAGE Publishing.
Chicago Style (17th ed.) CitationRetraction Notice: Dihydromyricetin Exhibits Antitumor Activity in Nasopharyngeal Cancer Cell Through Antagonizing Wnt/β-Catenin Signaling. SAGE Publishing, 2025.
MLA (9th ed.) CitationRetraction Notice: Dihydromyricetin Exhibits Antitumor Activity in Nasopharyngeal Cancer Cell Through Antagonizing Wnt/β-Catenin Signaling. SAGE Publishing, 2025.
Warning: These citations may not always be 100% accurate.